The question of the study: P (Problem)  Type 1 Diabetes Mellitus "The trial ended 24 hours after trial drug administration, or earlier if plasma glucose levels exceeded 11.1 mmol/l in the absence of glucose infusion."
Are the results valid? Analysis
All in all the patients were at evaluation interpretation considered adequately,
BUT:
"Pharmacokinetic data from one patient were excluded due to unexpectedly high insulin serum concentrations."
"Furthermore, data from one patient at one visit were excluded (0.3 IU / kg NPH insulin) because the pharmacokinetic data suggested i.v. rather than s.c. administration."
